Cybin Stock Quote Today

CYBN
 Stock
  

USD 0.56  0.02  3.45%   

Market Performance
0 of 100
Odds Of Distress
Over 62
Cybin is selling for 0.56 as of the 29th of June 2022. This is a -3.45 percent decrease since the beginning of the trading day. The stock's open price was 0.58. Cybin has more than 62 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Cybin Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of April 2022 and ending today, the 29th of June 2022. Click here to learn more.
Fiscal Year End
March
IPO Date
13th of September 2019
Category
Healthcare
ISIN
CA23256X1006
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. It has also developed EMBARK, a psychedelic-assisted psychotherapy. Cybin operates under Biotechnology classification in the United States and is traded on NYSEMKT Exchange. The company has 160.36 M outstanding shares of which 3.44 M shares are currently shorted by private and institutional investors with about 4.18 trading days to cover. More on Cybin Inc

Moving together with Cybin

0.73BCRXBiocryst Pharma Upward RallyPairCorr

Cybin Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Cybin's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cybin or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Cybin Inc generated a negative expected return over the last 90 days
Cybin Inc has high historical volatility and very poor performance
Cybin Inc has some characteristics of a very speculative penny stock
Cybin Inc has high likelihood to experience some financial distress in the next 2 years
Cybin Inc was previously known as CYBIN INC and was traded on PNK Exchange under the symbol CLXPF.
Net Loss for the year was (63.31 M) with loss before overhead, payroll, taxes, and interest of (311 K).
Cybin Inc currently holds about 63.58 M in cash with (42.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.39.
Cybin Inc has a frail financial position based on the latest SEC disclosures
Roughly 22.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: Cybin Announces Additional Adelia Milestone Achievement - Yahoo Finance
Older SymbolCLXPF
Fama & French Classification
Average Analyst Recommendation
Analysts covering Cybin report their recommendations after researching Cybin's financial statements, talking to executives and customers, or listening in on Cybin's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Cybin Inc. The Cybin consensus assessment is calculated by taking the average forecast from all of the analysts covering Cybin.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Cybin Inc based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Cybin Inc financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 2 - FrailDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares149.3 M167.3 M
Fairly Down
Increasing
Slightly volatile
Weighted Average Shares Diluted149.3 M167.3 M
Fairly Down
Increasing
Slightly volatile
Total Assets78.6 M84.1 M
Notably Down
Increasing
Slightly volatile
Total Liabilities6.9 M7.9 M
Fairly Down
Increasing
Slightly volatile
Current Assets55.1 M58.4 M
Notably Down
Increasing
Slightly volatile
Current Liabilities6.7 M7.9 M
Fairly Down
Increasing
Slightly volatile
Gross Margin0.210.21
Steady
Decreasing
Slightly volatile
Asset Turnover0.01610.0162
Slightly Down
Decreasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Cybin's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong HoldUndervalued
Cybin Inc (CYBN) is traded on NYSEMKT Exchange in USA. It is located in 100 King Street West and employs 38 people. Cybin Inc was previously known as CYBIN INC and was traded on PNK Exchange under the symbol CLXPF. Cybin is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with current market capitalization of 93.62 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cybin's market, we take the total number of its shares issued and multiply it by Cybin's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Cybin Inc conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 160.36 M outstanding shares of which 3.44 M shares are currently shorted by private and institutional investors with about 4.18 trading days to cover. Cybin Inc currently holds about 63.58 M in cash with (42.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.39.
Check Cybin Probability Of Bankruptcy
Ownership
Cybin Inc retains a total of 160.36 Million outstanding shares. Cybin Inc retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Cybin Ownership Details

Cybin Stock Price Odds Analysis

What are Cybin's target price odds to finish over the current price? Proceeding from a normal probability distribution, the odds of Cybin jumping above the current price in 90 days from now is about 77.34%. The Cybin Inc probability density function shows the probability of Cybin stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Cybin has a beta of 0.852 suggesting Cybin Inc market returns are very sensitive to returns on the market. As the market goes up or down, Cybin is expected to follow. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Cybin Inc is significantly underperforming DOW.
  Odds Below 0.56HorizonTargetOdds Above 0.56
22.59%90 days
 0.56 
77.34%
Based on a normal probability distribution, the odds of Cybin to move above the current price in 90 days from now is about 77.34 (This Cybin Inc probability density function shows the probability of Cybin Stock to fall within a particular range of prices over 90 days) .

Cybin Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Cybin that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Cybin's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cybin's value.
InstituionSecurity TypeTotal SharesValue
Orbimed Advisors LlcCommon Shares10.5 M8.6 M
Perry Creek Capital LpCommon Shares1.5 M1.3 M
View Cybin Diagnostics

Cybin Historical Income Statement

Cybin Inc Income Statement is one of the three primary financial statements used for reporting Cybin's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Cybin Inc revenue and expense. Cybin Income Statement primarily focuses on the company's revenues and expenses during a particular period.
View More Fundamentals

Cybin Stock Against Markets

Picking the right benchmark for Cybin stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cybin stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cybin is critical whether you are bullish or bearish towards Cybin Inc at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Cybin without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Investing Cybin Inc

You need to understand the risk of investing before taking a position in Cybin. The danger of trading Cybin Inc is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Cybin is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Cybin. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Cybin Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Cybin Inc information on this page should be used as a complementary analysis to other Cybin's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Cybin Stock analysis

When running Cybin Inc price analysis, check to measure Cybin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cybin is operating at the current time. Most of Cybin's value examination focuses on studying past and present price action to predict the probability of Cybin's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cybin's price. Additionally, you may evaluate how the addition of Cybin to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Is Cybin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cybin. If investors know Cybin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cybin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
94.3 M
Return On Assets
-0.41
Return On Equity
-0.74
The market value of Cybin Inc is measured differently than its book value, which is the value of Cybin that is recorded on the company's balance sheet. Investors also form their own opinion of Cybin's value that differs from its market value or its book value, called intrinsic value, which is Cybin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cybin's market value can be influenced by many factors that don't directly affect Cybin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cybin's value and its price as these two are different measures arrived at by different means. Investors typically determine Cybin value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cybin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.